Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein S21 pseudogene 2 is a processed pseudogene of the ribosomal protein S21 family. It derives from the duplication and mutation of the protein-coding RPS21 gene and is present at multiple locations in the human genome. Unlike protein-coding genes, pseudogenes like RPS21P2 are generally non-functional and do not produce a functional ribosomal protein. RPS21P2 is not a drug target, does not participate in biological functions directly, and is not associated with diseases or therapeutic intervention. If you are seeking information on a ribosomal protein drug target, you may want to refer to the full-length, functional gene RPS21 (Ribosomal protein S21) rather than its pseudogene counterpart.
None applicable (no drug targets activity on this pseudogene)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S21 pseudogene 2 (RPS21P2).